(Q36918008)

17 August 2017

1 reference

title

Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles (English)

1 reference

17 August 2017

0 references

cardiovascular disease

1 reference

0 references

Gregory M Lanza

1

1 reference

17 August 2017

Patrick M Winter

2

1 reference

17 August 2017

Shelton D Caruthers

3

1 reference

17 August 2017

Michael S Hughes

4

1 reference

17 August 2017

Tillmann Cyrus

5

1 reference

17 August 2017

Jon N Marsh

6

1 reference

17 August 2017

Anne M Neubauer

7

1 reference

17 August 2017

Kathy C Partlow

8

1 reference

17 August 2017

Samuel A Wickline

9

1 reference

17 August 2017

language of work or name

1 reference

1 October 2006

1 reference

17 August 2017

1 reference

17 August 2017

volume

1

1 reference

17 August 2017

issue

3

1 reference

17 August 2017

page(s)

321-329

1 reference

Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F17435889.1.3.321

The potential role of perfluorochemicals (PFCs) in diagnostic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.1.3.321

Improved molecular imaging contrast agent for detection of human thrombus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.1.3.321

1H/19F magnetic resonance molecular imaging with perfluorocarbon nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.1.3.321

In vitro demonstration using 19F magnetic resonance to augment molecular imaging with paramagnetic perfluorocarbon nanoparticles at 1.5 Tesla

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.1.3.321

Sonic activation of molecularly-targeted nanoparticles accelerates transmembrane lipid delivery to cancer cells through contact-mediated mechanisms: implications for enhanced local drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.1.3.321

Pathologic assessment of the vulnerable human coronary plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.1.3.321

Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.1.3.321

Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.1.3.321

In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.1.3.321

In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.1.3.321

Quantitative "magnetic resonance immunohistochemistry" with ligand-targeted (19)F nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.1.3.321

Images in cardiovascular medicine. Serial high-spatial-resolution, multisequence magnetic resonance imaging studies identify fibrous cap rupture and penetrating ulcer into carotid atherosclerotic plaque.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.1.3.321

Impact of coronary vasa vasorum functional structure on coronary vessel wall perfusion distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.1.3.321

Functional anatomy and hemodynamic characteristics of vasa vasorum in the walls of porcine coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.1.3.321

Neovascularization in atherectomy specimens from patients with unstable angina: implications for pathogenesis of unstable angina.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.1.3.321

Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.1.3.321

Structure of human methionine aminopeptidase-2 complexed with fumagillin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.1.3.321

Molecular MR imaging of melanoma angiogenesis with alphanubeta3-targeted paramagnetic nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.1.3.321

Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.1.3.321

Relaxivity of liposomal paramagnetic MRI contrast agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.1.3.321

Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.1.3.321

Sirolimus eluting stent implantation for patients with multivessel disease: rationale for the Arterial Revascularisation Therapies Study part II (ARTS II).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.1.3.321

Rapamycin eluting stent: the onset of a new era in interventional cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.1.3.321

Late angiographic stent thrombosis (LAST) events with drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.1.3.321

Symposium presentations. How to become a cardiovascular investigator

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.1.3.321

Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.1.3.321

Coronary stent thrombosis in the current drug-eluting stent era: insights from the ERACI III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.1.3.321

MR three-dimensional molecular imaging of intramural biomarkers with targeted nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.1.3.321

Generic, simple risk stratification model for heart valve surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.1.3.321

Plaque Neovascularization Is Increased in Ruptured Atherosclerotic Lesions of Human Aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.1.3.321

Clinical and pharmacokinetic study of TNP-470, an angiogenesis inhibitor, in combination with paclitaxel and carboplatin in patients with solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.1.3.321

Long-term clinical outcome after stent implantation in coronary arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.1.3.321

21 January 2018

Identifiers

DOI

10.2217/17435889.1.3.321

1 reference

17 August 2017

1 reference